TickerFacts.

Anika Therapeutics, Inc. (ANIK): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$4.36M
Year ended 2025-12-31
$562.0K
Trailing 12 months to 2026-06-30
-17.5%
5-year compound annual growth
-17.7%
10-year compound annual growth
$38.42M2009-12-31: -$867.5K2010-12-31: $5.07M2011-12-31: $8.77M2012-12-31: $9.04M2013-12-31: $24.72M2014-12-31: $38.42M2015-12-31: $30.69M2016-12-31: $10.43M2017-12-31: $31.83M2018-12-31: $30.26M2019-12-31: $34.18M2020-12-31: $11.44M2021-12-31: $3.25M2022-12-31: -$3.08M2023-12-31: -$7.21M2024-12-31: -$2.33M2025-12-31: $4.36M$4.36M
2009-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$4.36Mn/m2026-03-03, From 2025-01-01
2024-12-31-$2.33Mn/m2026-03-03, From 2024-01-01
2023-12-31-$7.21Mn/m2026-03-03, From 2023-01-01
2022-12-31-$3.08Mn/m2025-03-17, From 2022-01-01
2021-12-31$3.25M-71.5%2024-03-15, From 2021-01-01
2020-12-31$11.44M-66.5%2023-03-16, From 2020-01-01
2019-12-31$34.18M+12.9%2022-03-11, From 2019-01-01
2018-12-31$30.26M-4.9%2021-04-26, From 2018-01-01
2017-12-31$31.83M+205.1%2020-03-06, From 2017-01-01
2016-12-31$10.43M-66.0%2019-02-27, From 2016-01-01
2015-12-31$30.69Mn/c2018-02-27, From 2015-01-01
2014-12-31$38.42M+55.4%2017-02-24, From 2014-01-01
2013-12-31$24.72M+173.4%2016-03-10, From 2013-01-01
2012-12-31$9.04M+3.1%2015-03-13, From 2012-01-01
2011-12-31$8.77M+73.1%2014-03-13, From 2011-01-01
2010-12-31$5.07Mn/m2013-03-14, From 2010-01-01
2009-12-31-$867.5Kn/a2012-03-13, From 2009-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Anika Therapeutics, Inc. (ANIK)2025-12-31$4.36Mn/m
Orasure Technologies Inc (OSUR)2025-12-31-$53.22Mn/m
Beta Bionics, Inc. (BBNX)2025-12-31-$56.22Mn/m
NeuroPace Inc (NPCE)2025-12-31-$11.34Mn/m
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30-$116.59Mn/m
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$10.16Mn/m
Pulmonx Corp (LUNG)2025-12-31-$32.83Mn/m
InfuSystem Holdings, Inc (INFU)2025-12-31$23.85M+23.1%
Neuronetics, Inc. (STIM)2025-12-31-$21.18Mn/m

Compare ANIK, OSUR, BBNX, NPCE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗